Description
H89 is an inhibitor of PKA that is used to study the effects of PKA signaling in research models. H89 may also inhibit Rho-associated protein kinase (ROCK), S6K1, MSK1, PKBa, and MAPKAP-K1b.
H89
Product ID H0003
Cas No. 127243-85-0
Purity ≥98%
| Product Unit Size | Cost | Quantity | Stock |
|---|
Product Info
| Cas No. | 127243-85-0 |
|---|---|
| Purity | ≥98% |
| Formula | C20H20BrN3O2S |
| Formula Wt. | 446.36 |
| Chemical Name | N-(2-[P-Bromocinnamylamino]-ethyl)-5-isoquinolinesulfonmide |
| IUPAC Name | N-[2-[[(E)-3-(4-bromophenyl)prop-2-enyl]amino]ethyl]isoquinoline-5- sulfonamide;dihydrochloride |
| Melting Point | 141-143°C |
| Solubility | Soluble in DMSO or ethanol:water (1:1). |
| Appearance | White powder |
Shipping and Storage
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
Downloads
| MSDS | |
|---|---|
| Info Sheet |
References
Choi S, Kim MY, Joo KY, et al. Modafinil inhibits K(Ca)3.1 currents and muscle contraction via a cAMP-dependent mechanism. Pharmacol Res. 2012 Jul;66(1):51-9. PMID: 22414869.
Rogers RC, Hermann GE. Tumor necrosis factor activation of vagal afferent terminal calcium is blocked by cannabinoids. J Neurosci. 2012 Apr 11;32(15):5237-41. PMID: 22496569.